Transducin β-Like Protein 1 Controls Multiple Oncogenic Networks in Diffuse Large B Cell Lymphoma

The authors showed that, unlike normal B cells, diffuse large B cell lymphoma (DLBCL) cells express abundant levels of transducin b-like protein 1 and its overexpression correlates with poor clinical outcome regardless of DLBCL molecular subtype.